Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 63

    Amgen to reduce price of its cholesterol drug Repatha starting 2020

    Amgen to reduce price of its cholesterol drug Repatha starting 2020

    Medical Dialogues Bureau3 Nov 2019 9:15 AM IST
    Amgen launched the lower-price option of Repatha last October, selling the drug to some patients under the list price of $5,850 per year because the...
    Bristol-Myers Opdivo, Yervoy show promise in lung cancer trial

    Bristol-Myers Opdivo, Yervoy show promise in lung cancer trial

    Medical Dialogues Bureau3 Nov 2019 9:00 AM IST
    Bristol-Myers Squibb said its therapies when administered alongside two courses of chemotherapy demonstrated superior overall survival compared to...
    Andhra Pradesh: Blast at Chemist shop, 2 dead

    Andhra Pradesh: Blast at Chemist shop, 2 dead

    Farhat Nasim2 Nov 2019 4:25 PM IST
    Though the cause of the fire is unknown, yet it is suspected that a blast in the AC compressor caused the incident. The cops found the dead body of...
    Lupin gets USFDA nod for generic version of Levoxyl tablets to treat hypothyroidism

    Lupin gets USFDA nod for generic version of Levoxyl tablets to treat hypothyroidism

    Medical Dialogues Bureau2 Nov 2019 10:00 AM IST
    The product is a generic version of King Pharmaceuticals Research and Development LLC's Levoxyl tablets in same strengths, Lupin said.New Delhi: Drug...
    Alkem Labs closes USFDA inspection of Baddi, Daman facility with 2 observations

    Alkem Labs closes USFDA inspection of Baddi, Daman facility with 2 observations

    Medical Dialogues Bureau2 Nov 2019 9:45 AM IST
    New Delhi: Drugmaker Alkem Laboratories (Alkem Labs) recently informed that the company has received 2 observations from the US health regulator for...
    Tests indicate heartburn drug Zantac does not form carcinogen in users: USFDA

    Tests indicate heartburn drug Zantac does not form carcinogen in users: USFDA

    Medical Dialogues Bureau2 Nov 2019 9:30 AM IST
    Zantac sold over-the-counter in the United States by French drugmaker Sanofi SA, and some of its generic versions, have been recalled due to possible...
    Revenue from operations stood at Rs 2005 crore in Q2: Torrent Pharma

    Revenue from operations stood at Rs 2005 crore in Q2: Torrent Pharma

    Medical Dialogues Bureau2 Nov 2019 9:15 AM IST
    Consolidated revenue from operations stood at Rs 2,005 crore for the quarter under consideration as against Rs 1,894 crore for the same period last...
    Mirati Therapeutics oral drug MRTX849 shrinks tumours in early-stage trial

    Mirati Therapeutics oral drug MRTX849 shrinks tumours in early-stage trial

    Medical Dialogues Bureau2 Nov 2019 9:00 AM IST
    Out of 17 patients enrolled in the Phase 1 trial of Mirati Therapeutics' oral drug MRTX849, 12 have been evaluated, including six with lung cancer and...
    Cadila Healthcare gets EIR from USFDA for Baddi facility

    Cadila Healthcare gets EIR from USFDA for Baddi facility

    Medical Dialogues Bureau1 Nov 2019 2:11 PM IST
    New Delhi: Drug firm Cadila Healthcare on Thursday said its Baddi facility in Himachal Pradesh has received establishment inspection report (EIR) from...
    Boehringer Ingelheim, The Defeat-NCD Partnership join hands to fight non-communicable diseases

    Boehringer Ingelheim, The Defeat-NCD Partnership join hands to fight non-communicable diseases

    Medical Dialogues Bureau1 Nov 2019 2:07 PM IST
    Germany – Boehringer Ingelheim, one of the world’s leading pharmaceutical companies, announced today its partnership with The Defeat-NCD Partnership,...
    Iconic Crocin Pain Relief to get a relaunch

    Iconic Crocin Pain Relief to get a relaunch

    Garima1 Nov 2019 1:49 PM IST
    GSK markets five varients of Crocin namely Crocin Advance, Crocin 650 Mg, Crocin Pain Relief, Crocin Cold & Flu and Crocin's Children Range...
    GSK Pharma reports Q2 profit at Rs 503 crore

    GSK Pharma reports Q2 profit at Rs 503 crore

    Medical Dialogues Bureau1 Nov 2019 9:15 AM IST
    GSK Pharmaceuticals continues to drive improved operational efficiencies reflecting in earnings before interest, tax, depreciation and amortisation...
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Why Family Health Insurance Plan needs a Timely Re-Evaluation?

    Why Family Health Insurance Plan needs a Timely Re-Evaluation?

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Health Insurance- The Best Backup Plan in Today

    Health Insurance- The Best Backup Plan in Today's Times

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok